Recent studies have shown that COL6A2 plays a key role in many tumors, especially lung adenocarcinoma, and its expression level can be used as a prognostic predictor and a potential marker for targeted therapies (48). This evidence concerns the gene COL6A2 and lung adenocarcinoma.